Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

TAVR Highlights: ‘A huge victory for patient care’ | Tracking acute kidney injuries | How AFib impacts outcomes

News You Need to Know Today
TAVR Highlights: ‘A huge victory for patient care’ | Tracking acute kidney injuries | How AFib impacts outcomes
Thursday, January 11, 2024
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: TAVR

Self-expanding TAVR system with new sealing cuff linked to high success rate, favorable outcomes

The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023. 

READ MORE >
Navitor TAVR valve in the Abbott booth at TCT 2023. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

Self-expanding TAVR system with new sealing cuff linked to high success rate, favorable outcomes

Share on Twitter Share on Facebook Share on Linkedin
Navitor TAVR valve in the Abbott booth at TCT 2023. Photo by Dave Fornell
The valve, designed with a new-look sealing cuff for limiting paravalvular regurgitation, gained FDA approval in January 2023. 
READ MORE >

‘A huge victory for patient care’: Next-gen TAVR valve helps cardiologists target more patients

Sponsored by Medtronic

“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”

READ MORE >
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
Share on Twitter Share on Facebook Share on Linkedin

‘A huge victory for patient care’: Next-gen TAVR valve helps cardiologists target more patients

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”
READ MORE >

TAVR after mitral valve replacement linked to positive outcomes, but heart teams must plan ahead

Researchers in India performed TAVR on two relatively young patients with a preexisting mechanical mitral valve, sharing their experience in a new case report. The group highlighted the importance of planning ahead.

READ MORE >
TAVR after mitral valve replacement
Share on Twitter Share on Facebook Share on Linkedin

TAVR after mitral valve replacement linked to positive outcomes, but heart teams must plan ahead

Share on Twitter Share on Facebook Share on Linkedin
TAVR after mitral valve replacement
Researchers in India performed TAVR on two relatively young patients with a preexisting mechanical mitral valve, sharing their experience in a new case report. The group highlighted the importance of planning ahead.
READ MORE >

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Balloon-expandable TAVR valves linked to superior 1-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
Asian patients are rarely represented in large TAVR trials, the authors wrote, so they focused on nearly 1,200 patients from South Korea to provide a fresh perspective. 
READ MORE >

TAVR patients face a higher risk of stroke for up to 2 years

A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer. 

READ MORE >
Stroke - head with text
Share on Twitter Share on Facebook Share on Linkedin

TAVR patients face a higher risk of stroke for up to 2 years

Share on Twitter Share on Facebook Share on Linkedin
Stroke - head with text
A majority of strokes after TAVR occur in the first 48 hours, but patients remain at a significantly higher risk for much longer. 
READ MORE >

Good to great: 5 ways to help sonographers deliver better echocardiograms and improve the diagnosis of severe AS

Sponsored by Medtronic

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 

READ MORE >
sonographer echo
Share on Twitter Share on Facebook Share on Linkedin

Good to great: 5 ways to help sonographers deliver better echocardiograms and improve the diagnosis of severe AS

Sponsored by Medtronic

Share on Twitter Share on Facebook Share on Linkedin
sonographer echo
Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 
READ MORE >

Acute kidney injury after TAVR linked to certain risks, but most patients have a full recovery

“These findings are highly pertinent in a clinical setting," researchers explained. 

READ MORE >
Damaged Organ
Share on Twitter Share on Facebook Share on Linkedin

Acute kidney injury after TAVR linked to certain risks, but most patients have a full recovery

Share on Twitter Share on Facebook Share on Linkedin
Damaged Organ
“These findings are highly pertinent in a clinical setting," researchers explained. 
READ MORE >

Early survival data favor valve-in-valve TAVR over redo SAVR—long-term data flip the script

Valve-in-valve TAVR outperforms redo SAVR for the first six months after treatment, according to a new meta-analysis published in the American Journal of Cardiology. Then, however, things begin to shift.

READ MORE >
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Share on Twitter Share on Facebook Share on Linkedin

Early survival data favor valve-in-valve TAVR over redo SAVR—long-term data flip the script

Share on Twitter Share on Facebook Share on Linkedin
According to the U.S. government, Asante Health System and one of its surgeons knowingly submitted false claims to Medicare, Medicaid and TRICARE for more than six years. Heart surgery surgeons.
Valve-in-valve TAVR outperforms redo SAVR for the first six months after treatment, according to a new meta-analysis published in the American Journal of Cardiology. Then, however, things begin to shift.
READ MORE >

AFib before and after TAVR linked to significant risks

The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure. 

READ MORE >
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
Share on Twitter Share on Facebook Share on Linkedin

AFib before and after TAVR linked to significant risks

Share on Twitter Share on Facebook Share on Linkedin
Elderly patient doctor. Despite an expanded indication from the FDA and lower prices, patient access to these cholesterol-lowering medications remains a significant issue.
The new study included data on patients who presented for TAVR with preexisting AFib as well as those who developed new-onset AFib after the procedure. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Key FDA approvals | Radiation during heart scans | Whole-body MRI provider offers AI-powered CCTA | 3D echo & CHD
Cardiologists & AI policies | FDA clears ‘world’s smallest camera’ | Prior authorization doing harm | Comparing DOACs
Faster coronary IVL catheter impresses | CCTA now an essential tool | Treating ‘no-option’ chest pain patients | RDN updates
Radiotracer shortage winding down | FDA clears new catheter | The high costs of healthcare | Vascular surgeons deliver value
TAVR Highlights: A new implantation technique | The world's first polymeric valve | Planning ahead | Oversizing boosts survival
Medtronic announces $550M acquisition | Faster IVL catheter impresses | Who do Americans trust? | Burnout among surgeons
Cardiologist develops new heart device | FDA approves pacing lead for LBBAP | A warning about universal screening

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …18
    • Page 19
    • Page 20
    • Page 21
    • Current page 22
    • Page 23
    • Page 24
    • Page 25
    • Page 26 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup